» Articles » PMID: 14249387

IMMUNOLOGICAL DISTURBANCES IN MYASTHENIA GRAVIS WITH A REPORT OF HASHIMOTO'S DISEASE DEVELOPING AFTER THYMECTOMY

Overview
Date 1964 Dec 1
PMID 14249387
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making.

Gerischer L, Doksani P, Hoffmann S, Meisel A BioDrugs. 2025; 39(2):185-213.

PMID: 39869260 PMC: 11906560. DOI: 10.1007/s40259-024-00701-1.


Risk of incident autoimmune diseases in patients with thymectomy.

Lin T, Chang Y, Hou T, Hsu H, Lin S, Chen W Ann Clin Transl Neurol. 2020; 7(7):1072-1082.

PMID: 32478484 PMC: 7359128. DOI: 10.1002/acn3.51055.


The Non-Dystrophic Myopathies.

Pearce J Postgrad Med J. 2011; 41(476):347-55.

PMID: 21313712 PMC: 2483008. DOI: 10.1136/pgmj.41.476.347.


Thymic function and disease processes.

Br Med J. 2010; 3(5563):447-8.

PMID: 20791314 PMC: 1842696.


Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.

Scherbaum W, Schumm F, Maisch B, Muller C, Fluchter S, SEIF F Klin Wochenschr. 1983; 61(10):509-15.

PMID: 6876683 DOI: 10.1007/BF01488718.


References
1.
FELTKAMP T, van der GELD , KRUYFF K, OOSTERHUIS H . Antinuclear factor in myasthenia gravis. Lancet. 1963; 1(7282):667. DOI: 10.1016/s0140-6736(63)91302-3. View

2.
Beckett A, Matthews D . Vitamin B12 in diabetes mellitus. Clin Sci. 1962; 23:361-70. View

3.
NASTUK W, Strauss A, OSSERMAN K . Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis. Am J Med. 1959; 26(3):394-409. DOI: 10.1016/0002-9343(59)90248-7. View

4.
Daly J, Jackson E . CASE OF HASHIMOTO'S DISEASE WITH MYASTHENIA GRAVIS. Br Med J. 1964; 1(5385):748. PMC: 1815178. DOI: 10.1136/bmj.1.5385.748. View

5.
Partridge R, Duthie J . Incidence of macrocytic anaemia in rheumatoid arthritis. Br Med J. 1963; 1(5323):89-91. PMC: 2122583. DOI: 10.1136/bmj.1.5323.89. View